RMR Wealth Builders’s Regeneron Pharmaceuticals REGN Stock Holding History

RMR Wealth Builders’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.33M	Buy	5,339 +1,466	+38%	+$998K	0.21%	72
2026 Q1	$2.99M	Buy	3,873 +414	+12%	+$317K	0.24%	65
2025 Q4	$2.67M	Buy	3,459 +470	+16%	+$319K	0.21%	62
2025 Q3	$1.68M	Buy	2,989 +255	+9%	+$144K	0.14%	85
2025 Q2	$1.44M	Buy	2,734 +593	+28%	+$331K	0.13%	94
2025 Q1	$1.36M	Buy	+2,141	New	+$1.47M	0.14%	92
2021 Q2	–	Sell	-70	Closed	-$33K	–	576
2021 Q1	$33K	Hold	70	–	–	0.01%	436
2020 Q4	$34K	Buy	+70	New	+$37.8K	0.02%	297

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

RMR Wealth Builders's REGN Position: Q2 2026 in Review

RMR Wealth Builders increased its Regeneron Pharmaceuticals (REGN) stake by 38% in Q2 2026, buying an estimated $998K and bringing the position to 5,339 shares worth $3.33M. The position accounts for 0.21% of the portfolio, ranked #72.

RMR Wealth Builders first reported a position in REGN in Q4 2020 and has held it in 8 quarters since. 366 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

RMR Wealth Builders held 5,339 shares of Regeneron Pharmaceuticals worth $3.33M as of Q2 2026.
RMR Wealth Builders bought 1,466 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $998K.
Regeneron Pharmaceuticals made up 0.21% of RMR Wealth Builders's portfolio in Q2 2026, its #72 holding.
RMR Wealth Builders first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 8 quarters since.
366 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on RMR Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.